FindTrial
Sign In

Asrigdara (Abnormal uterine bleeding): A randomised control trail of Triphala Aragvadha kashay

Asrigdara(Abnormal uterine bleeding): A randomised control trial of Triphala Aragvadha kashay - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098853
Enrollment
30
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Aishwarya Alone
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female subjects (18-50 years) complaints of excessive, prolonged abnormal uterine bleeding or intermenstrual bleeding, Subjects with Hb % more than 8 gm%., Subjects having organic pathologies like fibroid (up to 4cm) & polyp, Hyperplasia, (Endometrial thickness up to 10 mm

Exclusion criteria

Exclusion criteria: Subjects with thyroid dysfunction, Malignancies. (Ca cervix, Endometrial carcinoma, ovarian cancer, vulvar carcinoma, trophoblastic neoplasia), Subjects with threatened or spontaneous abortion or pregnancy related bleeding.

Design outcomes

Primary

MeasureTime frame
eduction in the menstrual blood loss. Reduction in the PBAC score less than 100.Timepoint: Follow up for 3 consequent cycles—

Secondary

MeasureTime frame
Regular menstrual cycle. Improvement in Hb %Timepoint: Follow up for 3 consequent cycles—

Countries

India

Contacts

Public ContactDr Seema gholap

College of Ayurved, Bharati Vidyapeeth (Deemed to be university) ,Pune 43

seema.gholap@bharatividyapeeth.edu9881076009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026